Healthcare

United States Nanomedicine Market Report 2017

  • QYR1563878
  • 113 Pages
  • September 2017
  • Healthcare
Download Sample    Get Discount   
 
In this report, the United States Nanomedicine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

The West

Southwest

The Middle Atlantic

New England

The South

The Midwest

with sales (volume), revenue (value), market share and growth rate of Nanomedicine in these regions, from 2012 to 2022 (forecast).

United States Nanomedicine market competition by top manufacturers/players, with Nanomedicine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

GE Healthcare

Johnson & Johnson

Mallinckrodt plc

Merck & Co. Inc.

Nanosphere Inc.

Pfizer Inc.

Sigma-Tau Pharmaceuticals Inc.

Smith & Nephew PLC

Stryker Corp

Teva Pharmaceutical Industries Ltd.

UCB (Union chimique belge) S.A

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Regenerative Medicine

In-vitro & In-vivo Diagnostics

Vaccines

Drug Delivery

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Nanomedicine for each application, including

Clinical Cardiology

Urology

Genetics

Orthopedics

Ophthalmology

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

United States Nanomedicine Market Report 2017

1 Nanomedicine Overview

1.1 Product Overview and Scope of Nanomedicine

1.2 Classification of Nanomedicine by Product Category

1.2.1 United States Nanomedicine Market Size (Sales Volume) Comparison by Type (2012-2022)

1.2.2 United States Nanomedicine Market Size (Sales Volume) Market Share by Type (Product Category) in 2016

1.2.3 Regenerative Medicine

1.2.4 In-vitro & In-vivo Diagnostics

1.2.5 Vaccines

1.2.6 Drug Delivery

1.3 United States Nanomedicine Market by Application/End Users

1.3.1 United States Nanomedicine Market Size (Consumption) and Market Share Comparison by Application (2012-2022)

1.3.2 Clinical Cardiology

1.3.3 Urology

1.3.4 Genetics

1.3.5 Orthopedics

1.3.6 Ophthalmology

1.4 United States Nanomedicine Market by Region

1.4.1 United States Nanomedicine Market Size (Value) Comparison by Region (2012-2022)

1.4.2 The West Nanomedicine Status and Prospect (2012-2022)

1.4.3 Southwest Nanomedicine Status and Prospect (2012-2022)

1.4.4 The Middle Atlantic Nanomedicine Status and Prospect (2012-2022)

1.4.5 New England Nanomedicine Status and Prospect (2012-2022)

1.4.6 The South Nanomedicine Status and Prospect (2012-2022)

1.4.7 The Midwest Nanomedicine Status and Prospect (2012-2022)

1.5 United States Market Size (Value and Volume) of Nanomedicine (2012-2022)

1.5.1 United States Nanomedicine Sales and Growth Rate (2012-2022)

1.5.2 United States Nanomedicine Revenue and Growth Rate (2012-2022)

2 United States Nanomedicine Market Competition by Players/Suppliers

2.1 United States Nanomedicine Sales and Market Share of Key Players/Suppliers (2012-2017)

2.2 United States Nanomedicine Revenue and Share by Players/Suppliers (2012-2017)

2.3 United States Nanomedicine Average Price by Players/Suppliers (2012-2017)

2.4 United States Nanomedicine Market Competitive Situation and Trends

2.4.1 United States Nanomedicine Market Concentration Rate

2.4.2 United States Nanomedicine Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Nanomedicine Manufacturing Base Distribution, Sales Area, Product Type

3 United States Nanomedicine Sales (Volume) and Revenue (Value) by Region (2012-2017)

3.1 United States Nanomedicine Sales and Market Share by Region (2012-2017)

3.2 United States Nanomedicine Revenue and Market Share by Region (2012-2017)

3.3 United States Nanomedicine Price by Region (2012-2017)

4 United States Nanomedicine Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

4.1 United States Nanomedicine Sales and Market Share by Type (Product Category) (2012-2017)

4.2 United States Nanomedicine Revenue and Market Share by Type (2012-2017)

4.3 United States Nanomedicine Price by Type (2012-2017)

4.4 United States Nanomedicine Sales Growth Rate by Type (2012-2017)

5 United States Nanomedicine Sales (Volume) by Application (2012-2017)

5.1 United States Nanomedicine Sales and Market Share by Application (2012-2017)

5.2 United States Nanomedicine Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Nanomedicine Players/Suppliers Profiles and Sales Data

6.1 GE Healthcare

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Nanomedicine Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 GE Healthcare Nanomedicine Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Johnson & Johnson

6.2.2 Nanomedicine Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Johnson & Johnson Nanomedicine Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Mallinckrodt plc

6.3.2 Nanomedicine Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Mallinckrodt plc Nanomedicine Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Merck & Co. Inc.

6.4.2 Nanomedicine Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Merck & Co. Inc. Nanomedicine Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Nanosphere Inc.

6.5.2 Nanomedicine Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Nanosphere Inc. Nanomedicine Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Pfizer Inc.

6.6.2 Nanomedicine Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Pfizer Inc. Nanomedicine Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Sigma-Tau Pharmaceuticals Inc.

6.7.2 Nanomedicine Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Sigma-Tau Pharmaceuticals Inc. Nanomedicine Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Smith & Nephew PLC

6.8.2 Nanomedicine Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Smith & Nephew PLC Nanomedicine Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 Stryker Corp

6.9.2 Nanomedicine Product Category, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Stryker Corp Nanomedicine Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 Teva Pharmaceutical Industries Ltd.

6.10.2 Nanomedicine Product Category, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Teva Pharmaceutical Industries Ltd. Nanomedicine Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

6.11 UCB (Union chimique belge) S.A

7 Nanomedicine Manufacturing Cost Analysis

7.1 Nanomedicine Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Nanomedicine

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Nanomedicine Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Nanomedicine Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Nanomedicine Market Size (Value and Volume) Forecast (2017-2022)

11.1 United States Nanomedicine Sales Volume, Revenue Forecast (2017-2022)

11.2 United States Nanomedicine Sales Volume Forecast by Type (2017-2022)

11.3 United States Nanomedicine Sales Volume Forecast by Application (2017-2022)

11.4 United States Nanomedicine Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Nanomedicine

Figure United States Nanomedicine Market Size (K Units) by Type (2012-2022)

Figure United States Nanomedicine Sales Volume Market Share by Type (Product Category) in 2016

Figure Regenerative Medicine Product Picture

Figure In-vitro & In-vivo Diagnostics Product Picture

Figure Vaccines Product Picture

Figure Drug Delivery Product Picture

Figure United States Nanomedicine Market Size (K Units) by Application (2012-2022)

Figure United States Sales Market Share of Nanomedicine by Application in 2016

Figure Clinical Cardiology Examples

Table Key Downstream Customer in Clinical Cardiology

Figure Urology Examples

Table Key Downstream Customer in Urology

Figure Genetics Examples

Table Key Downstream Customer in Genetics

Figure Orthopedics Examples

Table Key Downstream Customer in Orthopedics

Figure Ophthalmology Examples

Table Key Downstream Customer in Ophthalmology

Figure United States Nanomedicine Market Size (Million USD) by Region (2012-2022)

Figure The West Nanomedicine Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest Nanomedicine Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Middle Atlantic Nanomedicine Revenue (Million USD) and Growth Rate (2012-2022)

Figure New England Nanomedicine Revenue (Million USD) and Growth Rate (2012-2022)

Figure The South of US Nanomedicine Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Midwest Nanomedicine Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Nanomedicine Sales (K Units) and Growth Rate (2012-2022)

Figure United States Nanomedicine Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Nanomedicine Market Major Players Product Sales Volume (K Units) (2012-2017)

Table United States Nanomedicine Sales (K Units) of Key Players/Suppliers (2012-2017)

Table United States Nanomedicine Sales Share by Players/Suppliers (2012-2017)

Figure 2016 United States Nanomedicine Sales Share by Players/Suppliers

Figure 2017 United States Nanomedicine Sales Share by Players/Suppliers

Figure United States Nanomedicine Market Major Players Product Revenue (Million USD) (2012-2017)

Table United States Nanomedicine Revenue (Million USD) by Players/Suppliers (2012-2017)

Table United States Nanomedicine Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 United States Nanomedicine Revenue Share by Players/Suppliers

Figure 2017 United States Nanomedicine Revenue Share by Players/Suppliers

Table United States Market Nanomedicine Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)

Figure United States Market Nanomedicine Average Price (USD/Unit) of Key Players/Suppliers in 2016

Figure United States Nanomedicine Market Share of Top 3 Players/Suppliers

Figure United States Nanomedicine Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Nanomedicine Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Nanomedicine Product Category

Table United States Nanomedicine Sales (K Units) by Region (2012-2017)

Table United States Nanomedicine Sales Share by Region (2012-2017)

Figure United States Nanomedicine Sales Share by Region (2012-2017)

Figure United States Nanomedicine Sales Market Share by Region in 2016

Table United States Nanomedicine Revenue (Million USD) and Market Share by Region (2012-2017)

Table United States Nanomedicine Revenue Share by Region (2012-2017)

Figure United States Nanomedicine Revenue Market Share by Region (2012-2017)

Figure United States Nanomedicine Revenue Market Share by Region in 2016

Table United States Nanomedicine Price (USD/Unit) by Region (2012-2017)

Table United States Nanomedicine Sales (K Units) by Type (2012-2017)

Table United States Nanomedicine Sales Share by Type (2012-2017)

Figure United States Nanomedicine Sales Share by Type (2012-2017)

Figure United States Nanomedicine Sales Market Share by Type in 2016

Table United States Nanomedicine Revenue (Million USD) and Market Share by Type (2012-2017)

Table United States Nanomedicine Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Nanomedicine by Type (2012-2017)

Figure Revenue Market Share of Nanomedicine by Type in 2016

Table United States Nanomedicine Price (USD/Unit) by Types (2012-2017)

Figure United States Nanomedicine Sales Growth Rate by Type (2012-2017)

Table United States Nanomedicine Sales (K Units) by Application (2012-2017)

Table United States Nanomedicine Sales Market Share by Application (2012-2017)

Figure United States Nanomedicine Sales Market Share by Application (2012-2017)

Figure United States Nanomedicine Sales Market Share by Application in 2016

Table United States Nanomedicine Sales Growth Rate by Application (2012-2017)

Figure United States Nanomedicine Sales Growth Rate by Application (2012-2017)

Table GE Healthcare Basic Information List

Table GE Healthcare Nanomedicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure GE Healthcare Nanomedicine Sales Growth Rate (2012-2017)

Figure GE Healthcare Nanomedicine Sales Market Share in United States (2012-2017)

Figure GE Healthcare Nanomedicine Revenue Market Share in United States (2012-2017)

Table Johnson & Johnson Basic Information List

Table Johnson & Johnson Nanomedicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Johnson & Johnson Nanomedicine Sales Growth Rate (2012-2017)

Figure Johnson & Johnson Nanomedicine Sales Market Share in United States (2012-2017)

Figure Johnson & Johnson Nanomedicine Revenue Market Share in United States (2012-2017)

Table Mallinckrodt plc Basic Information List

Table Mallinckrodt plc Nanomedicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Mallinckrodt plc Nanomedicine Sales Growth Rate (2012-2017)

Figure Mallinckrodt plc Nanomedicine Sales Market Share in United States (2012-2017)

Figure Mallinckrodt plc Nanomedicine Revenue Market Share in United States (2012-2017)

Table Merck & Co. Inc. Basic Information List

Table Merck & Co. Inc. Nanomedicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Merck & Co. Inc. Nanomedicine Sales Growth Rate (2012-2017)

Figure Merck & Co. Inc. Nanomedicine Sales Market Share in United States (2012-2017)

Figure Merck & Co. Inc. Nanomedicine Revenue Market Share in United States (2012-2017)

Table Nanosphere Inc. Basic Information List

Table Nanosphere Inc. Nanomedicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Nanosphere Inc. Nanomedicine Sales Growth Rate (2012-2017)

Figure Nanosphere Inc. Nanomedicine Sales Market Share in United States (2012-2017)

Figure Nanosphere Inc. Nanomedicine Revenue Market Share in United States (2012-2017)

Table Pfizer Inc. Basic Information List

Table Pfizer Inc. Nanomedicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Pfizer Inc. Nanomedicine Sales Growth Rate (2012-2017)

Figure Pfizer Inc. Nanomedicine Sales Market Share in United States (2012-2017)

Figure Pfizer Inc. Nanomedicine Revenue Market Share in United States (2012-2017)

Table Sigma-Tau Pharmaceuticals Inc. Basic Information List

Table Sigma-Tau Pharmaceuticals Inc. Nanomedicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Sigma-Tau Pharmaceuticals Inc. Nanomedicine Sales Growth Rate (2012-2017)

Figure Sigma-Tau Pharmaceuticals Inc. Nanomedicine Sales Market Share in United States (2012-2017)

Figure Sigma-Tau Pharmaceuticals Inc. Nanomedicine Revenue Market Share in United States (2012-2017)

Table Smith & Nephew PLC Basic Information List

Table Smith & Nephew PLC Nanomedicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Smith & Nephew PLC Nanomedicine Sales Growth Rate (2012-2017)

Figure Smith & Nephew PLC Nanomedicine Sales Market Share in United States (2012-2017)

Figure Smith & Nephew PLC Nanomedicine Revenue Market Share in United States (2012-2017)

Table Stryker Corp Basic Information List

Table Stryker Corp Nanomedicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Stryker Corp Nanomedicine Sales Growth Rate (2012-2017)

Figure Stryker Corp Nanomedicine Sales Market Share in United States (2012-2017)

Figure Stryker Corp Nanomedicine Revenue Market Share in United States (2012-2017)

Table Teva Pharmaceutical Industries Ltd. Basic Information List

Table Teva Pharmaceutical Industries Ltd. Nanomedicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Teva Pharmaceutical Industries Ltd. Nanomedicine Sales Growth Rate (2012-2017)

Figure Teva Pharmaceutical Industries Ltd. Nanomedicine Sales Market Share in United States (2012-2017)

Figure Teva Pharmaceutical Industries Ltd. Nanomedicine Revenue Market Share in United States (2012-2017)

Table UCB (Union chimique belge) S.A Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Nanomedicine

Figure Manufacturing Process Analysis of Nanomedicine

Figure Nanomedicine Industrial Chain Analysis

Table Raw Materials Sources of Nanomedicine Major Players/Suppliers in 2016

Table Major Buyers of Nanomedicine

Table Distributors/Traders List

Figure United States Nanomedicine Sales Volume (K Units) and Growth Rate Forecast (2017-2022)

Figure United States Nanomedicine Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure United States Nanomedicine Price (USD/Unit) Trend Forecast (2017-2022)

Table United States Nanomedicine Sales Volume (K Units) Forecast by Type (2017-2022)

Figure United States Nanomedicine Sales Volume (K Units) Forecast by Type (2017-2022)

Figure United States Nanomedicine Sales Volume (K Units) Forecast by Type in 2022

Table United States Nanomedicine Sales Volume (K Units) Forecast by Application (2017-2022)

Figure United States Nanomedicine Sales Volume (K Units) Forecast by Application (2017-2022)

Figure United States Nanomedicine Sales Volume (K Units) Forecast by Application in 2022

Table United States Nanomedicine Sales Volume (K Units) Forecast by Region (2017-2022)

Table United States Nanomedicine Sales Volume Share Forecast by Region (2017-2022)

Figure United States Nanomedicine Sales Volume Share Forecast by Region (2017-2022)

Figure United States Nanomedicine Sales Volume Share Forecast by Region in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370